JAGSNPHARM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > jagsnpharm

Technical Analysis

Technical Strength: 5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 48.6. According to RSI analysis, jagsnpharm is marginally weak. 4.0 JAGSNPHARM RSI Chart
MACD (?) MACD: 0.209 and Signal Line: 0.062. According to MACD analysis, jagsnpharm is technically strong. 8.0 JAGSNPHARM MACD Chart
Simple Moving Average (?) Price just got below it's 20-day simple moving average which is a negative signal. According to simple moving average analysis, jagsnpharm is facing resistance at 32.3 and support level is at 31.942. 2.0 JAGSNPHARM Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 50-day exponential moving average which is a negative signal. Price just got below it's 20-day exponential moving average which is a negative signal. According to exponential moving average analysis, jagsnpharm is in a strong downtrend. Major resistance levels are 32.48916, 32.88904, 35.87961. 0.0 JAGSNPHARM Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.461. 5.0 JAGSNPHARM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 32.474, 33.3 and 34.126. Support is at 29.8. 7.0 JAGSNPHARM Fibonacci Retracement Chart
Average True Range (?) ATR: 1.88 NA JAGSNPHARM Average True Range Chart
Average Directional Index (?) ADX is 16.4 which means JAGSNPHARM is in a trading range and there is no trend. NA JAGSNPHARM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 17, 2017
Open Price 33.0
High Price 33.05
Low Price 32.0
Close Price 32.15
Absolute Change -1.3
Percentage Change -3.89%
Weekly Change 1.74%
Monthly Change -4.88%
Yearly Change -21.9%
52-week high 50.85
52-week low 25.8
Corporate Actions
ExDate Purpose
September 21, 2017 AGM/DIV-RE 0.10 PER SH
September 21, 2016 AGM/DIV-RE 0.10 PER SHARE
September 25, 2014 AGM/DIV-RE 0.50 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.96
Confidence in Beta2.15%
Market Capital Rs. 84.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 1.24
TTM Price-to-Earnings (P/E) Ratio 25.9
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 17 October 2017: Deliverable Quantity:0 NA JAGSNPHARM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 16 October 2017: Daily Volatility:0.6419 NA JAGSNPHARM Annualized Daily Volatility (Spot Price) Chart


October 05, 2017 Disclosure under SEBI Takeover Regulations Jagsonpal Pharmaceuticals Limited has submitted to the Exchange vide letter dated October 03, 2017 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
October 03, 2017 Demise Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Demise of Mr Govind Deo, Non- Executive Independent Director of the company on September 30, 2017.
See all Announcements

Board Meetings

Date Meeting Date Purpose
May 22, 2017 May 28, 2017 Results/Dividend Inter alia to consider and approve the Audited Financial Results of the Company for the year from April 1st, 2016 to March 31, 2017 and consider Dividend,
February 03, 2017 February 14, 2017 Results Inter alia to consider and approve the Un-audited Financial Results (provisional) of the Company for the third quarter and nine months ended December 31, 2016.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 30.7 Rs. 31.35 Rs. 31.75 Rs. 32.4 Rs. 32.8 Rs. 33.45 Rs. 33.85